Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-24 @ 6:38 PM
NCT ID:
NCT04779957
Eligibility Criteria:
Inclusion Criteria:
* Adult recipients,
* affiliated to the social security
* requiring a graft nephrectomy, with a project to retransplantation
Exclusion Criteria:
* combined transplantations, PRA \>20%.
* Patient under protective measures,
* Rituximab used for immunosuppression induction
* Previous transplants not removed,
* Active infectious complications at graft nephrectomy, need for immunosuppressive treatments after graft nephrectomy,
* Participation to another interventional studies using Rituximab, polyclonal antibodies, Eculizumab, or Tocilizumab.
* adults under guardianship or other legal protection, deprived of their liberty by judicial or administrative decision,
* pregnancy or breastfeeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04779957
Study Brief:
Protocol Section:
NCT04779957